$5.60
-0.91-13.98%
At close: -
$5.60
0.000.00%
After Hours: 4:02 PM EDT
Comments
Loading...
Karyopharm Therapeutics Insider Trading Activity | NASDAQ:KPTI | Benzinga
Track the latest Karyopharm Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Karyopharm Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Karyopharm Therapeutics Inc Insiders Doing?
At Karyopharm Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 25.64K shares worth $161.26K, meanwhile, insiders have report no purchases in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 5, 2025, Richard Paulson, the company's PRESIDENT AND CEO sold 4.1K shares for $0.65 each.
- On January 7, 2025, Richard Paulson, the company's PRESIDENT AND CEO sold 4.06K shares for $0.78 each.
- On March 6, 2025, Kristin Abate, the company's CHIEF ACCOUNTING OFFICER sold 571 shares for $6.29 each.
Ownership Statistics for Karyopharm Therapeutics Inc
Shares Outstanding
8.416M
Insider Shares Owned
5.475M
Insider Percentage Owned
65.1%
Institutional Shares Held
11.281M
Institutional Percentage Held
13.7%
| Mar 06, 2025 | Sohanya Cheng | EVP & CHIEF COMMERCIAL OFFICER | -3.44K | $6.29 | -$21.67K | SELL | -9.12% | 34.31K | Mar 04 | View |
| Mar 06, 2025 | Richard Paulson | PRESIDENT AND CEO | -11.69K | $6.29 | -$73.56K | SELL | -12.35% | 82.98K | Mar 04 | View |
| Mar 06, 2025 | Reshma Rangwala | EVP & CHIEF MEDICAL OFFICER | -3.59K | $6.29 | -$22.56K | SELL | -10.92% | 29.27K | Mar 04 | View |
| Mar 06, 2025 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -3.55K | $6.29 | -$22.32K | SELL | -11.46% | 27.41K | Mar 04 | View |
| Mar 06, 2025 | Kristin Abate | CHIEF ACCOUNTING OFFICER | -571.00 | $6.29 | -$3.59K | SELL | -5.55% | 9.71K | Mar 04 | View |
| Mar 06, 2025 | Michael Mano | SVP, GENERAL COUNSEL&SECRETARY | -2.79K | $6.29 | -$17.57K | SELL | -11.72% | 21.05K | Mar 04 | View |
| Feb 19, 2025 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -5.91K | $0.63 | -$3.73K | SELL | -1.81% | 320.71K | Feb 18 | View |
| Feb 05, 2025 | Richard Paulson | PRESIDENT AND CEO | -4.10K | $0.65 | -$2.66K | SELL | -0.36% | 1.12M | Feb 04 | View |
| Jan 07, 2025 | Richard Paulson | PRESIDENT AND CEO | -4.05K | $0.78 | -$3.18K | SELL | -0.36% | 1.12M | Jan 06 | View |
| Dec 05, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.62K | $0.81 | -$2.93K | SELL | -0.32% | 1.13M | Dec 04 | View |
| Nov 06, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.67K | $0.91 | -$3.35K | SELL | -0.32% | 1.13M | Nov 05 | View |
| Oct 07, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.61K | $0.88 | -$3.17K | SELL | -0.32% | 1.14M | Oct 04 | View |
| Sep 05, 2024 | Michael Mano | SVP, GENERAL COUNSEL&SECRETARY | -3.97K | $0.72 | -$2.87K | SELL | -1.43% | 273.88K | Sep 04 | View |
| Sep 05, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.67K | $0.72 | -$2.65K | SELL | -0.32% | 1.14M | Sep 04 | View |
| Sep 05, 2024 | Michael Mason | EVP, CFO & TREASURER | -7.05K | $0.72 | -$5.09K | SELL | -1.77% | 391.05K | Sep 04 | View |
| Sep 05, 2024 | Sohanya Cheng | EVP & CHIEF COMMERCIAL OFFICER | -5.36K | $0.72 | -$3.87K | SELL | -1.31% | 404.05K | Sep 04 | View |
| Aug 08, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.61K | $0.93 | -$3.36K | SELL | -0.31% | 1.14M | Aug 06 | View |
| Jul 31, 2024 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -2.88K | $1.06 | -$3.06K | SELL | -0.87% | 326.63K | Jul 30 | View |
| Jul 09, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.62K | $0.85 | -$3.08K | SELL | -0.31% | 1.15M | Jul 05 | View |
| Jun 07, 2024 | Deepika Pakianathan | — | -818.04K | $0.96 | -$785.03K | SELL | -100.00% | 0.00 | Jun 05 - Jun 07 | View |
| Jun 06, 2024 | Michael Mason | EVP, CFO & TREASURER | -652.00 | $0.99 | -$645.48 | SELL | -0.16% | 398.10K | Jun 04 | View |
| Jun 06, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.59K | $0.99 | -$3.56K | SELL | -0.31% | 1.15M | Jun 04 | View |
| Jun 04, 2024 | Deepika Pakianathan | — | -906.18K | $0.97 | -$880.69K | SELL | -99.13% | 7.91K | May 31 - Jun 04 | View |
| May 07, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.58K | $1.13 | -$4.04K | SELL | -0.31% | 1.15M | May 06 | View |
| Apr 23, 2024 | Reshma Rangwala | EVP & CHIEF MEDICAL OFFICER | -6.79K | $1.17 | -$7.94K | SELL | -1.94% | 342.93K | Apr 22 | View |
| Apr 05, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.56K | $1.29 | -$4.60K | SELL | -0.31% | 1.16M | Apr 04 | View |
| Mar 06, 2024 | Richard Paulson | PRESIDENT AND CEO | -3.57K | $1.30 | -$4.64K | SELL | -0.31% | 1.16M | Mar 05 | View |
| Mar 04, 2024 | Reshma Rangwala | EVP & CHIEF MEDICAL OFFICER | -21.64K | $1.18 | -$25.49K | SELL | -5.83% | 349.72K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -22.47K | $1.18 | -$26.47K | SELL | -6.38% | 329.51K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Michael Mason | EVP, CFO & TREASURER | -33.85K | $1.18 | -$39.79K | SELL | -7.82% | 398.76K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Michael Mano | SVP, GENERAL COUNSEL&SECRETARY | -20.55K | $1.18 | -$24.15K | SELL | -6.89% | 277.85K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Sohanya Cheng | EVP & CHIEF COMMERCIAL OFFICER | -26.95K | $1.18 | -$31.68K | SELL | -6.41% | 393.51K | Feb 29 - Mar 01 | View |
| Mar 04, 2024 | Richard Paulson | PRESIDENT AND CEO | -99.84K | $1.18 | -$117.40K | SELL | -7.90% | 1.16M | Feb 29 - Mar 01 | View |
| Feb 29, 2024 | Michael Mason | EVP, CFO & TREASURER | 185.66K | $1.32 | -$3.37K | GRANT | 75.18% | 432.61K | Feb 27 - Feb 28 | View |
| Feb 20, 2024 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -5.85K | $1.33 | -$7.78K | SELL | -3.45% | 163.77K | Feb 15 | View |
| Feb 08, 2024 | Michael Mason | EVP, CFO & TREASURER | -4.21K | $1.59 | -$6.67K | SELL | -1.67% | 246.94K | Feb 06 | View |
| Feb 08, 2024 | Richard Paulson | PRESIDENT AND CEO | -4.01K | $1.59 | -$6.37K | SELL | -0.49% | 821.45K | Feb 06 | View |
| Jan 08, 2024 | Richard Paulson | PRESIDENT AND CEO | -4.11K | $0.82 | -$3.37K | SELL | -0.52% | 783.47K | Jan 04 | View |
| Dec 05, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.62K | $0.79 | -$2.86K | SELL | -0.46% | 787.58K | Dec 04 | View |
| Nov 07, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.61K | $0.92 | -$3.32K | SELL | -0.45% | 791.20K | Nov 06 | View |
| Oct 05, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.59K | $1.27 | -$4.56K | SELL | -0.45% | 794.81K | Oct 04 | View |
| Sep 12, 2023 | Garen Bohlin | — | 41.14K | $1.22 | $49.99K | BUY | 1028.50% | 45.14K | Sep 12 | View |
| Sep 06, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.62K | $1.33 | -$4.82K | SELL | -0.45% | 798.40K | Sep 05 | View |
| Sep 05, 2023 | Michael Mason | EVP, CFO & TREASURER | -6.91K | $1.33 | -$9.20K | SELL | -2.82% | 237.82K | Sep 01 | View |
| Sep 05, 2023 | Michael Mano | SVP, GENERAL COUNSEL&SECRETARY | -3.89K | $1.33 | -$5.18K | SELL | -2.66% | 142.23K | Sep 01 | View |
| Sep 05, 2023 | Sohanya Cheng | EVP & CHIEF COMMERCIAL OFFICER | -7.42K | $1.33 | -$9.87K | SELL | -3.51% | 204.09K | Sep 01 | View |
| Aug 08, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.72K | $1.72 | -$6.40K | SELL | -0.46% | 802.02K | Aug 07 | View |
| Aug 01, 2023 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -2.85K | $1.70 | -$4.84K | SELL | -1.79% | 156.29K | Jul 28 | View |
| Jul 06, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.54K | $1.72 | -$6.09K | SELL | -0.44% | 805.74K | Jul 05 | View |
| Jun 12, 2023 | Sohanya Cheng | EVP & CHIEF COMMERCIAL OFFICER | -1.84K | $2.35 | -$4.32K | SELL | -0.86% | 211.50K | Jun 08 | View |
| Jun 07, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.54K | $2.24 | -$7.92K | SELL | -0.44% | 809.28K | Jun 05 | View |
| Jun 05, 2023 | Michael Mason | EVP, CFO & TREASURER | -631.00 | $2.22 | -$1.40K | SELL | -0.26% | 244.73K | Jun 02 | View |
| May 05, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.81K | $3.35 | -$12.75K | SELL | -0.47% | 812.81K | May 04 | View |
| Apr 24, 2023 | Reshma Rangwala | EVP & CHIEF MEDICAL OFFICER | -6.77K | $4.05 | -$27.42K | SELL | -4.10% | 158.23K | Apr 20 | View |
| Apr 05, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.50K | $3.97 | -$13.88K | SELL | -0.43% | 816.62K | Apr 04 | View |
| Mar 07, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.51K | $3.16 | -$11.08K | SELL | -0.43% | 820.12K | Mar 06 | View |
| Mar 02, 2023 | Stephen Mitchener | SVP, CHIEF BUSINESS OFFICER | 53.64K | $3.03 | -$19.26K | GRANT | 71.84% | 128.31K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Michael Mano | SVP, GENERAL COUNSEL&SECRETARY | 63.12K | $3.03 | -$20.83K | GRANT | 76.05% | 146.12K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Sohanya Cheng | EVP & CHIEF COMMERCIAL OFFICER | 88.76K | $3.03 | -$34.05K | GRANT | 72.80% | 210.69K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Michael Mason | EVP, CFO & TREASURER | 83.80K | $3.03 | -$33.94K | GRANT | 51.86% | 245.36K | Feb 28 - Mar 01 | View |
| Mar 02, 2023 | Richard Paulson | PRESIDENT AND CEO | 218.97K | $3.03 | -$100.06K | GRANT | 36.21% | 823.62K | Feb 28 - Mar 01 | View |
| Mar 01, 2023 | Michael Mason | EVP, CFO & TREASURER | -2.80K | $3.04 | -$8.51K | SELL | -1.70% | 161.57K | Feb 27 | View |
| Feb 17, 2023 | Stuart Poulton | EVP, CHIEF DEVELOPMENT OFFICER | -5.87K | $3.19 | -$18.72K | SELL | -8.38% | 64.13K | Feb 15 | View |
| Feb 08, 2023 | Michael Mason | EVP, CFO & TREASURER | -4.14K | $3.40 | -$14.08K | SELL | -2.46% | 164.37K | Feb 06 | View |
| Feb 08, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.95K | $3.40 | -$13.43K | SELL | -0.65% | 604.65K | Feb 06 | View |
| Jan 05, 2023 | Richard Paulson | PRESIDENT AND CEO | -3.92K | $3.27 | -$12.82K | SELL | -0.64% | 608.61K | Jan 04 | View |
| Dec 06, 2022 | Richard Paulson | PRESIDENT AND CEO | -3.49K | $5.17 | -$18.04K | SELL | -0.57% | 612.53K | Dec 05 | View |
| Nov 08, 2022 | Richard Paulson | PRESIDENT AND CEO | -3.49K | $4.54 | -$15.86K | SELL | -0.56% | 616.02K | Nov 04 | View |
| Oct 05, 2022 | Richard Paulson | PRESIDENT AND CEO | -3.49K | $5.87 | -$20.47K | SELL | -0.56% | 619.51K | Oct 04 | View |
| Sep 09, 2022 | Richard Paulson | PRESIDENT AND CEO | -3.48K | $5.23 | -$18.20K | SELL | -0.56% | 623.00K | Sep 08 | View |
| Aug 05, 2022 | Richard Paulson | PRESIDENT AND CEO | -2.31K | $4.48 | -$10.37K | SELL | -0.37% | 626.48K | Aug 04 | View |
| Jul 11, 2022 | Richard Paulson | PRESIDENT AND CEO | -2.12K | $5.18 | -$10.95K | SELL | -0.34% | 628.79K | Jul 08 | View |
| Jun 14, 2022 | Sohanya Cheng | CHIEF COMMERCIAL OFFICER | -1.55K | $5.21 | -$8.07K | SELL | -1.70% | 89.95K | Jun 13 | View |
| Jun 10, 2022 | Deepika Pakianathan | DIRECTOR | -538.78K | $6.38 | -$3.43M | SELL | -97.00% | 16.67K | Jun 08 - Jun 10 | View |
| Jun 08, 2022 | Richard Paulson | PRESIDENT AND CEO | -2.54K | $5.76 | -$14.64K | SELL | -0.40% | 630.91K | Jun 07 | View |
| Jun 06, 2022 | Michael Mason | EVP, CFO, TREASURER | -601.00 | $6.04 | -$3.63K | SELL | -0.43% | 138.51K | Jun 03 | View |
| Mar 02, 2022 | Ran Frenkel | EVP, CHIEF DEV. OFFICER | 66.59K | $10.24 | -$17.03K | GRANT | 65.47% | 168.29K | Feb 28 | View |
| Mar 02, 2022 | Michael Mason | EVP, CFO & TREASURER | 85.80K | $10.24 | -$24.55K | GRANT | 160.96% | 139.11K | Feb 28 | View |
| Mar 02, 2022 | Sharon Shacham | CHIEF SCIENTIFIC OFFICER | 8.55K | $10.24 | -$127.48K | GRANT | 1.21% | 713.76K | Feb 28 | View |
| Mar 02, 2022 | Michael Kauffman | DIRECTOR | 8.55K | $10.24 | -$127.48K | GRANT | 0.96% | 898.13K | Feb 28 | View |
| Feb 22, 2022 | Jatin Shah | EVP, CHIEF MEDICAL OFFICER | -1.31K | $12.12 | -$15.83K | SELL | -1.00% | 129.45K | Feb 17 | View |
| Feb 22, 2022 | Ran Frenkel | EVP, CHIEF DEV. OFFICER | -2.93K | $12.12 | -$35.51K | SELL | -2.80% | 101.70K | Feb 17 | View |
| Feb 22, 2022 | Sharon Shacham | CHIEF SCIENTIFIC OFFICER | -18.17K | $12.12 | -$220.25K | SELL | -2.53% | 698.98K | Feb 17 | View |
| Feb 22, 2022 | Michael Kauffman | DIRECTOR | -18.17K | $12.12 | -$220.25K | SELL | -1.97% | 904.36K | Feb 17 | View |
| Feb 09, 2022 | Jatin Shah | EVP, CHIEF MEDICAL OFFICER | -1.70K | $9.86 | -$16.80K | SELL | -1.29% | 130.76K | Feb 07 | View |
| Feb 09, 2022 | Ran Frenkel | EVP, CHIEF DEV. OFFICER | -1.99K | $9.86 | -$19.64K | SELL | -1.87% | 104.63K | Feb 07 | View |
| Feb 09, 2022 | Michael Mason | EVP, CFO & TREASURER | -3.95K | $9.86 | -$38.93K | SELL | -6.89% | 53.31K | Feb 07 | View |
| Feb 09, 2022 | Michael Kauffman | DIRECTOR | -13.47K | $9.86 | -$132.85K | SELL | -1.45% | 913.45K | Feb 07 | View |
| Feb 09, 2022 | Sharon Shacham | CHIEF SCIENTIFIC OFFICER | -13.47K | $9.86 | -$132.85K | SELL | -1.87% | 708.06K | Feb 07 | View |
| Dec 03, 2021 | Stephen Mitchener | SVP, CHIEF BUSINESS OFFICER | -499.00 | $6.69 | -$3.34K | SELL | -13.15% | 3.30K | Dec 02 | View |
| Jun 03, 2021 | Stephen Mitchener | SVP, CHIEF BUSINESS OFFICER | -528.00 | $9.29 | -$4.91K | SELL | -17.60% | 2.47K | Jun 02 | View |
| May 11, 2021 | Jatin Shah | EVP, CHIEF MEDICAL OFFICER | 23.25K | $8.60 | $199.99K | BUY | 21.42% | 131.80K | May 07 | View |
| May 10, 2021 | Garen Bohlin | DIRECTOR | 4.00K | $7.82 | $31.28K | BUY | ∞ | 4.00K | May 06 | View |
| Mar 23, 2021 | Sharon Shacham | PRESIDENT & CSO | -4.00K | $12.39 | -$49.55K | SELL | -0.24% | 1.63M | Mar 18 | View |
| Mar 23, 2021 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | -4.00K | $12.39 | -$49.55K | SELL | -0.24% | 1.63M | Mar 18 | View |
| Feb 22, 2021 | Jatin Shah | EVP, CHIEF MEDICAL OFFICER | -1.19K | $14.83 | -$17.59K | SELL | -2.24% | 51.79K | Feb 18 | View |
| Feb 22, 2021 | Ran Frenkel | EVP, CHIEF DEV. OFFICER | -2.89K | $14.83 | -$42.82K | SELL | -5.89% | 46.13K | Feb 18 | View |
| Feb 22, 2021 | Sharon Shacham | PRESIDENT & CSO | -18.99K | $14.83 | -$281.64K | SELL | -3.20% | 575.13K | Feb 18 | View |
| Feb 22, 2021 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | -18.99K | $14.83 | -$281.64K | SELL | -2.39% | 776.45K | Feb 18 | View |
| Feb 17, 2021 | Tanya Lewis | EVP, CHIEF REG. AFFAIRS | -2.05K | $15.52 | -$31.75K | SELL | -33.06% | 4.14K | Feb 11 | View |
| Feb 17, 2021 | Jatin Shah | EVP, CHIEF MEDICAL OFFICER | 3.10K | $15.52 | -$27.13K | SELL-OPTIONS | 6.22% | 52.98K | Feb 11 - Feb 15 | View |
| Feb 17, 2021 | Ran Frenkel | EVP, CHIEF DEV. OFFICER | 7.63K | $15.52 | -$31.75K | SELL-OPTIONS | 18.43% | 49.01K | Feb 11 - Feb 15 | View |
| Feb 17, 2021 | Michael Mason | SVP, CFO & TREASURER | -2.86K | $15.52 | -$44.35K | SELL | -35.07% | 5.29K | Feb 11 | View |
| Feb 17, 2021 | Sharon Shacham | PRESIDENT & CSO | 30.36K | $15.52 | -$205.52K | SELL-OPTIONS | 5.48% | 584.62K | Feb 11 - Feb 15 | View |
| Feb 17, 2021 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | 30.36K | $15.52 | -$205.52K | SELL-OPTIONS | 4.02% | 785.95K | Feb 11 - Feb 15 | View |
| Dec 22, 2020 | Mansoor Raza Mirza | — | 0.00 | $11.71 | -$62.85K | OPTION EXERCISE | 0.00% | 0.00 | Dec 18 | View |
| Dec 08, 2020 | Mansoor Raza Mirza | — | 0.00 | $10.75 | -$212.78K | OPTION EXERCISE | 0.00% | 0.00 | Dec 07 | View |
| Dec 03, 2020 | Christopher B. Primiano | EVP, CBO, GC & SECRETARY | 0.00 | $13.98 | -$973.48K | SELL-OPTIONS | 0.00% | 4.52K | Dec 01 | View |
| Nov 04, 2020 | Tanya Lewis | — | 539.00 | $15.58 | -$3.52K | OPTION EXERCISE | ∞ | 539.00 | Oct 28 - Oct 30 | View |
| Nov 04, 2020 | Jatin Shah | EVP, CHIEF MEDICAL OFFICER | 1.82K | $19.46 | -$11.46K | SELL-OPTIONS | 4.41% | 43.23K | Jul 11 - Jul 15 | View |
| Nov 04, 2020 | Christopher B. Primiano | EVP, CBO, GC & SECRETARY | -772.00 | $14.92 | -$11.52K | SELL | -14.58% | 4.52K | Nov 02 | View |
| Oct 14, 2020 | Christopher B. Primiano | EVP, CBO, GC & SECRETARY | 0.00 | $13.04 | -$299.43K | SELL-OPTIONS | 0.00% | 4.65K | Oct 13 | View |
| Oct 14, 2020 | Michael Kauffman | — | 0.00 | $7.46 | -$111.44K | OPTION EXERCISE | 0.00% | 1.31M | Oct 12 | View |
| Oct 14, 2020 | Sharon Shacham | — | 0.00 | $7.46 | -$111.44K | OPTION EXERCISE | 0.00% | 1.31M | Oct 12 | View |
| Sep 10, 2020 | Christopher B. Primiano | — | 0.00 | $10.76 | -$84.86K | OPTION EXERCISE | 0.00% | 4.65K | Sep 08 | View |
| Aug 27, 2020 | John Demaree | — | 7.50K | $14.54 | $109.01K | PURCHASE | ∞ | 7.50K | Aug 26 | View |
| Aug 18, 2020 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | 0.00 | $7.52 | -$22.11K | SELL-OPTIONS | 0.00% | 1.31M | Aug 17 | View |
| Aug 18, 2020 | Sharon Shacham | PRESIDENT & CSO | 0.00 | $7.52 | -$22.11K | SELL-OPTIONS | 0.00% | 1.31M | Aug 17 | View |
| Jul 17, 2020 | Michael Kauffman | — | 0.00 | $9.73 | -$145.48K | OPTION EXERCISE | 0.00% | 1.31M | Jul 15 | View |
| Jul 17, 2020 | Sharon Shacham | — | 0.00 | $9.73 | -$145.48K | OPTION EXERCISE | 0.00% | 1.31M | Jul 15 | View |
| Jul 13, 2020 | Michael Kauffman | — | 0.00 | $12.01 | -$217.75K | OPTION EXERCISE | 0.00% | 756.49K | Jul 09 - Jul 10 | View |
| Jul 13, 2020 | Sharon Shacham | PRESIDENT & CSO | 0.00 | $12.01 | -$217.75K | SELL-OPTIONS | 0.00% | 555.12K | Jul 09 - Jul 10 | View |
| Jun 24, 2020 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | 0.00 | $10.02 | -$149.75K | SELL-OPTIONS | 0.00% | 1.31M | Jun 22 | View |
| Jun 24, 2020 | Sharon Shacham | PRESIDENT & CSO | 0.00 | $10.02 | -$149.75K | SELL-OPTIONS | 0.00% | 1.31M | Jun 22 | View |
| Jun 17, 2020 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | 0.00 | $8.20 | -$122.53K | SELL-OPTIONS | 0.00% | 1.31M | Jun 15 | View |
| Jun 17, 2020 | Sharon Shacham | — | 0.00 | $8.20 | -$122.53K | OPTION EXERCISE | 0.00% | 1.31M | Jun 15 | View |
| Jun 11, 2020 | Michael Kauffman | — | 0.00 | $11.53 | -$203.41K | OPTION EXERCISE | 0.00% | 756.49K | Jun 09 - Jun 10 | View |
| Jun 11, 2020 | Sharon Shacham | — | 0.00 | $11.53 | -$203.41K | OPTION EXERCISE | 0.00% | 555.12K | Jun 09 - Jun 10 | View |
| May 19, 2020 | Michael Kauffman | — | 0.00 | $9.68 | -$289.35K | OPTION EXERCISE | 0.00% | 1.31M | May 15 - May 18 | View |
| May 19, 2020 | Sharon Shacham | PRESIDENT & CSO | 0.00 | $9.68 | -$289.35K | SELL-OPTIONS | 0.00% | 1.31M | May 15 - May 18 | View |
| May 11, 2020 | Ran Frenkel | — | -1.97K | $20.00 | -$39.48K | SELL | -5.33% | 35.09K | May 07 | View |
| May 11, 2020 | Christopher B. Primiano | — | -6.71K | $13.14 | -$171.36K | OPTION EXERCISE | -59.09% | 4.65K | May 07 | View |
| May 11, 2020 | Sharon Shacham | — | 0.00 | $12.19 | -$223.13K | OPTION EXERCISE | 0.00% | 555.12K | May 07 | View |
| May 11, 2020 | Michael Kauffman | — | 0.00 | $12.19 | -$223.13K | OPTION EXERCISE | 0.00% | 756.49K | May 07 | View |
| Apr 10, 2020 | Michael Kauffman | CHIEF EXECUTIVE OFFICER | 0.00 | $12.19 | -$297.48K | SELL-OPTIONS | 0.00% | 756.49K | Apr 08 - Apr 09 | View |
| Apr 10, 2020 | Sharon Shacham | — | 0.00 | $12.19 | -$297.48K | OPTION EXERCISE | 0.00% | 555.12K | Apr 08 - Apr 09 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.